Chemed Corp. buy Royal Bank of Canada
Start price
30.10.23
/
50%
€530.00
Target price
30.10.24
€568.73
Performance (%)
-6.13%
Price
04.06.24
€498.00
Summary
This prediction is currently active. With a performance of -6.13%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. Dividends of €1.49 are taken into consideration when calculating the performance. This prediction currently runs until 30.10.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Chemed Corp. | 1.000% | 1.000% |
iShares Core DAX® | -1.042% | 2.220% |
iShares Nasdaq 100 | -1.361% | 3.207% |
iShares Nikkei 225® | -0.044% | -1.680% |
iShares S&P 500 | -0.480% | 2.165% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Chemed Corp. diskutieren
Chemed Co. (NYSE: CHE) had its price target raised by analysts at Royal Bank of Canada from $576.00 to $604.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat